Sulfamethoxazole/Sulfadiazine/Trimethoprim

磺胺甲噁唑/磺胺嘧啶/甲氧苄啶

Report date: 2022/03/01 14:05:48

Base Information

Drug NameSulfamethoxazole/Sulfadiazine/Trimethoprim
Drug Alias Name联磺甲氧苄啶Sulfamethoxazale，Sulfadiazine and Trimethoprim Tablets联磺甲氧苄啶君独克
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitorsDihydrofolate reductase inhibitors
TargetsDihydropteroate synthaseDihydrofolate reductase
Therapy Area/IndicationsOtitis MediaUrinary Tract InfectionsBronchitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes SulfamethoxazoleSulfadiazineTrimethoprim
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsOtitis MediaUrinary Tract InfectionsBronchitis
Inactive IndicationsN/A

Other Information

ATC CodeJ01EE
Related LinksN/A